ESR1 and breast neoplasm: While ARs showed inhibitory activity on ERα pathway with antiproliferative effect in ERα-positive breast tumor cells and ARs levels could be predictive of the outcome in luminal subtypes [21,22], their role is still unclear in TNBC.